Sign Up Today and Learn More About NUCLIDIUM Stock
Invest in or calculate the value of your shares in NUCLIDIUM or other pre-IPO companies through EquityZen's platform.
NUCLIDIUM Stock
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics.
About NUCLIDIUM Stock
Founded
2018
Industries
Software, Artificial Intelligence, Data and Analytics
NUCLIDIUM Press Mentions
Stay in the know about the latest news on NUCLIDIUM
Investments in women-led companies set a clear record
startupticker • Mar 08, 2026
Will radioligand therapies keep the momentum going in 2026?
labiotech • Feb 14, 2026
Clinical milestones bring startups closer to launching new therapies
startupticker • Oct 14, 2025
NUCLIDIUM to Present Clinical Data from Phase I/II Study for Copper-based PET-Diagnostic in Neuroendocrine Tumors at EANM 2025
globenewswire • Sep 17, 2025
Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand
labiotech • Sep 04, 2025
NUCLIDIUM Management
Leadership team at NUCLIDIUM
CEO and Founder
Leila Jaafar-Thiel
CFO
Claudia Halasz
Join now and verify your accreditation status to gain access to:
- NUCLIDIUM Current Valuation
- NUCLIDIUM Stock Price
- NUCLIDIUM Management
- Available deals in NUCLIDIUM and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- NUCLIDIUM Cap Table and Funding History by Share Class and Liquidity Preferences
- NUCLIDIUM Revenue and Financials
- NUCLIDIUM Highlights
- NUCLIDIUM Business Model
- NUCLIDIUM Risk Factors
- NUCLIDIUM Research Report from SACRA Research
Trading NUCLIDIUM Stock
How to invest in NUCLIDIUM stock?
Accredited investors can buy pre-IPO stock in companies like NUCLIDIUM through EquityZen funds. These investments are made available by existing NUCLIDIUM shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell NUCLIDIUM stock?
Shareholders can sell their NUCLIDIUM stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."